Last reviewed · How we verify

Prone hyperpolarized 3 helium gas scan — Competitive Intelligence Brief

Prone hyperpolarized 3 helium gas scan (Prone hyperpolarized 3 helium gas scan) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Pulmonology / Respiratory.

marketed Pulmonology / Respiratory Small molecule Live · refreshed every 30 min

Target snapshot

Prone hyperpolarized 3 helium gas scan (Prone hyperpolarized 3 helium gas scan) — Eric A. Hoffman. Hyperpolarized helium-3 gas imaging is a diagnostic imaging technique that uses polarized helium-3 gas inhaled by patients to visualize lung ventilation and detect regional ventilation defects.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Prone hyperpolarized 3 helium gas scan TARGET Prone hyperpolarized 3 helium gas scan Eric A. Hoffman marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Prone hyperpolarized 3 helium gas scan — Competitive Intelligence Brief. https://druglandscape.com/ci/prone-hyperpolarized-3-helium-gas-scan. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: